Authors
Loading...
CARM1 and PI3K inhibition shows synergistic anti-growth effects in triple-negative breast cancer cell lines, suggesting a novel therapeutic approach.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: